Clopidogrel as a part of double disaggregant therapy in ACS: a reasonable choice in complex clinical situations

Abstract

Based on the recommendations of the European Heart Society and the results of clinical and register studies, the article highlights the complex issues that arise when prescribing antiplatelet therapy in patients with acute coronary syndrome, including with concomitant atrial fibrillation (AF); the promising strategies for managing the risk of ischemic and hemorrhagic events are described. Also a clinical case of a patient with acute coronary syndrome and AF is presented, illustrating the objective complexity of correct selection of antiplatelet therapy in such patients.

Keywords

• acute coronary syndrome
• atrial fibrillation
• antithrombotic therapy
• clopidogrel